INR 20.96
(-4.86%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 785.00 INR | 19.14% |
2022 | 1996.00 INR | 132.91% |
2021 | 857.00 INR | 10.74% |
2020 | 773.89 INR | -24.68% |
2019 | 1027.42 INR | -37.12% |
2018 | 1633.92 INR | 83.77% |
2017 | 889.12 INR | -54.72% |
2016 | 1963.81 INR | 32.56% |
2015 | 1481.50 INR | 28.07% |
2014 | 1156.78 INR | 19.33% |
2013 | 969.37 INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 717.00 INR | -43.45% |
2023 Q4 | 1268.00 INR | 267.54% |
2023 FY | 2378.00 INR | 19.14% |
2023 Q1 | 259.00 INR | -89.85% |
2023 Q3 | 345.00 INR | -29.01% |
2023 Q2 | 486.00 INR | 87.64% |
2022 FY | 1996.00 INR | 132.91% |
2022 Q1 | 191.00 INR | -9.05% |
2022 Q3 | 162.00 INR | -19.8% |
2022 Q2 | 202.00 INR | 5.76% |
2022 Q4 | 2551.00 INR | 1474.69% |
2021 Q3 | 218.00 INR | -11.38% |
2021 Q4 | 210.00 INR | -3.67% |
2021 Q2 | 246.00 INR | 35.16% |
2021 Q1 | 182.00 INR | 84.05% |
2021 FY | 857.00 INR | 10.74% |
2020 Q3 | 482.00 INR | 7.83% |
2020 Q1 | 46.00 INR | -80.04% |
2020 FY | 773.89 INR | -24.68% |
2020 Q4 | 98.89 INR | -79.48% |
2020 Q2 | 447.00 INR | 871.74% |
2019 Q2 | 246.00 INR | -37.4% |
2019 FY | 1027.42 INR | -37.12% |
2019 Q3 | 156.00 INR | -36.59% |
2019 Q1 | 393.00 INR | -47.8% |
2019 Q4 | 230.42 INR | 47.7% |
2018 Q2 | 205.00 INR | -43.21% |
2018 FY | 1633.92 INR | 83.77% |
2018 Q1 | 361.00 INR | 1108.21% |
2018 Q3 | 315.00 INR | 53.66% |
2018 Q4 | 752.92 INR | 139.02% |
2017 Q1 | 168.00 INR | -71.9% |
2017 Q2 | 173.00 INR | 2.98% |
2017 Q4 | 29.88 INR | -94.83% |
2017 Q3 | 578.00 INR | 234.1% |
2017 FY | 889.12 INR | -54.72% |
2016 Q2 | 464.00 INR | -13.43% |
2016 Q1 | 536.00 INR | 56.5% |
2016 FY | 1963.81 INR | 32.56% |
2016 Q4 | 597.81 INR | 63.34% |
2016 Q3 | 366.00 INR | -21.12% |
2015 Q4 | 342.50 INR | -3.79% |
2015 FY | 1481.50 INR | 28.07% |
2015 Q3 | 356.00 INR | -11.0% |
2015 Q2 | 400.00 INR | 4.44% |
2015 Q1 | 383.00 INR | -17.42% |
2014 Q2 | 321.00 INR | 64.62% |
2014 Q3 | 177.00 INR | -44.86% |
2014 Q4 | 463.78 INR | 162.02% |
2014 FY | 1156.78 INR | 19.33% |
2014 Q1 | 195.00 INR | -48.6% |
2013 Q4 | 379.37 INR | 111.94% |
2013 Q3 | 179.00 INR | 4.68% |
2013 Q2 | 171.00 INR | 0.0% |
2013 FY | 969.37 INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Alfavision Overseas (India) Limited | 1.24 Million INR | 99.937% |
Biocon Limited | 40.9 Billion INR | 100.0% |
Blue Jet Healthcare Limited | 531.85 Million INR | 100.0% |
Concord Biotech Limited | 1.45 Billion INR | 100.0% |
Dishman Carbogen Amcis Limited | 5.14 Billion INR | 100.0% |
FERMENTA BIOTECH LIMITED | 754.2 Million INR | 100.0% |
GENOMIC VALLEY BIOTECH LIMITED | 375 Thousand INR | 99.791% |
Lyka Labs Limited | 599.4 Million INR | 100.0% |
Panacea Biotec Limited | 1.99 Billion INR | 100.0% |
SAMSRITA LABS LIMITED | 1.49 Million INR | 99.948% |
SMS Lifesciences India Limited | 602.96 Million INR | 100.0% |
Supriya Lifescience Limited | 1.08 Billion INR | 100.0% |
Syngene International Limited | 5.99 Billion INR | 100.0% |
TAKE Solutions Limited | 396.91 Million INR | 100.0% |
Titan Biotech Limited | 117.05 Million INR | 99.999% |
Transgene Biotek Limited | 5.39 Million INR | 99.985% |
Vanta Bioscience Limited | 38.95 Million INR | 99.998% |